0
Skip to Content
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data
BLOODPAC Portal
BLOODPAC Data Commons
Impact
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Resources
BLOODPAC Dictionary
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data
BLOODPAC Portal
BLOODPAC Data Commons
Impact
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Resources
BLOODPAC Dictionary
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
Folder: About
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Folder: Approach
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Folder: Data
Back
BLOODPAC Portal
BLOODPAC Data Commons
Folder: Impact
Back
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Folder: Resources
Back
BLOODPAC Dictionary
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
Medicare Coverage of Innovative Technology & Definition of “Reasonable & Necessary”
Laura Tramontozzi 11/2/20 Laura Tramontozzi 11/2/20

Medicare Coverage of Innovative Technology & Definition of “Reasonable & Necessary”

View Letter

Read More
Proposed Local Coverage Determination (LCD) - MolDX: Signatera™ and MinimalResidual Disease Testing for Colorectal Cancer (DL38290)
Laura Tramontozzi 11/20/19 Laura Tramontozzi 11/20/19

Proposed Local Coverage Determination (LCD) - MolDX: Signatera™ and MinimalResidual Disease Testing for Colorectal Cancer (DL38290)

View Letter

Read More
MolDX Local Coverage Determination (DL38043)
Laura Tramontozzi 6/19/19 Laura Tramontozzi 6/19/19

MolDX Local Coverage Determination (DL38043)

View Letter

Read More
CMS-1678-P — Hospital Outpatient Prospective Payment System, Proposed Rule – Potential Revisions to the Laboratory Date of Service Policy
Laura Tramontozzi 9/10/17 Laura Tramontozzi 9/10/17

CMS-1678-P — Hospital Outpatient Prospective Payment System, Proposed Rule – Potential Revisions to the Laboratory Date of Service Policy

View Letter

Read More

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mission is to accelerate the development, validation, and accessibility of liquid biopsy assays to improve outcomes for patients with cancer. To do so, we lead a pre-competitive collaborative infrastructure that enables the sharing of information and building of consensus among stakeholders in industry, academia, regulatory bodies, payers, and government agencies.